• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探测与 VEGF165 高亲和力的 DNA 适体的序列。

Probing high affinity sequences of DNA aptamer against VEGF165.

机构信息

Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.

出版信息

PLoS One. 2012;7(2):e31196. doi: 10.1371/journal.pone.0031196. Epub 2012 Feb 16.

DOI:10.1371/journal.pone.0031196
PMID:22359573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3281051/
Abstract

Vascular endothelial growth factor (VEGF(165)) is a potent angiogenic mitogen commonly overexpressed in cancerous cells. It contains two main binding domains, the receptor-binding domain (RBD) and the heparin-binding domain (HBD). This study attempted to identify the specific sequences of the VEa5 DNA aptamer that exhibit high binding affinity towards the VEGF(165) protein by truncating the original VEa5 aptamer into different segments. Using surface plasmon resonance (SPR) spectroscopy for binding affinity analysis, one of the truncated aptamers showed a >200-fold increase in the binding affinity for HBD. This truncated aptamer also exhibited high specificity to HBD with negligible binding affinity for VEGF(121), an isoform of VEGF lacking HBD. Exposing colorectal cancer cells to the truncated aptamer sequence further confirmed the binding affinity and specificity of the aptamer to the target VEGF(165) protein. Hence, our approach of aptamer truncation can potentially be useful in identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection.

摘要

血管内皮生长因子(VEGF(165))是一种在癌细胞中过度表达的强有力的血管生成有丝分裂原。它包含两个主要的结合域,受体结合域(RBD)和肝素结合域(HBD)。本研究试图通过截短原始 VEa5 适体来鉴定对 VEGF(165) 蛋白表现出高结合亲和力的 VEa5 DNA 适体的特定序列。通过表面等离子体共振(SPR)光谱法进行结合亲和力分析,一种截短的适体对 HBD 的结合亲和力增加了>200 倍。该截短的适体对 HBD 具有高度特异性,对缺乏 HBD 的 VEGF 同种型(VEGF(121))的结合亲和力可忽略不计。将结直肠癌细胞暴露于截短的适体序列进一步证实了适体与靶标 VEGF(165)蛋白的结合亲和力和特异性。因此,我们的适体截短方法可能有助于鉴定生物分子的高亲和力适体序列,并将其作为针对癌细胞检测的拮抗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/94a72d5d7dec/pone.0031196.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/2eebcddf70c2/pone.0031196.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/4b0cfd6983f5/pone.0031196.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/c0db18a9f870/pone.0031196.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/017619088117/pone.0031196.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/769e56aa0cea/pone.0031196.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/f23c7c4932cd/pone.0031196.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/d0a14309b8f5/pone.0031196.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/94a72d5d7dec/pone.0031196.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/2eebcddf70c2/pone.0031196.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/4b0cfd6983f5/pone.0031196.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/c0db18a9f870/pone.0031196.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/017619088117/pone.0031196.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/769e56aa0cea/pone.0031196.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/f23c7c4932cd/pone.0031196.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/d0a14309b8f5/pone.0031196.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1580/3281051/94a72d5d7dec/pone.0031196.g008.jpg

相似文献

1
Probing high affinity sequences of DNA aptamer against VEGF165.探测与 VEGF165 高亲和力的 DNA 适体的序列。
PLoS One. 2012;7(2):e31196. doi: 10.1371/journal.pone.0031196. Epub 2012 Feb 16.
2
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165.一种治疗性适配体通过特异性靶向VEGF165的肝素结合域来抑制血管生成。
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18902-7. doi: 10.1073/pnas.0509069102. Epub 2005 Dec 15.
3
In Vitro Selection of New DNA Aptamers for Human Vascular Endothelial Growth Factor 165.体外筛选人血管内皮生长因子 165 的新型 DNA 适体。
Chembiochem. 2020 Jul 16;21(14):2029-2036. doi: 10.1002/cbic.202000024. Epub 2020 Mar 30.
4
Post-ExSELEX stabilization of an unnatural-base DNA aptamer targeting VEGF165 toward pharmaceutical applications.用于药物应用的靶向VEGF165的非天然碱基DNA适配体的ExSELEX后稳定化
Nucleic Acids Res. 2016 Sep 6;44(15):7487-94. doi: 10.1093/nar/gkw619. Epub 2016 Jul 7.
5
Affinity improvement of a VEGF aptamer by in silico maturation for a sensitive VEGF-detection system.通过计算机模拟成熟提高 VEGF 适体的亲和力,用于灵敏的 VEGF 检测系统。
Anal Chem. 2013 Jan 15;85(2):1132-7. doi: 10.1021/ac303023d. Epub 2012 Dec 27.
6
Screening and improvement of an anti-VEGF DNA aptamer.筛选和改良一种抗 VEGF DNA 适体。
Molecules. 2010 Jan 7;15(1):215-25. doi: 10.3390/molecules15010215.
7
Improvement of the VEGF binding ability of DNA aptamers through in silico maturation and multimerization strategy.通过计算机模拟成熟和多聚化策略提高DNA适配体的VEGF结合能力
J Biotechnol. 2015 Oct 20;212:99-105. doi: 10.1016/j.jbiotec.2015.08.011. Epub 2015 Aug 21.
8
Investigating the antiproliferative activity of high affinity DNA aptamer on cancer cells.研究高亲和力 DNA 适体对癌细胞的抗增殖活性。
PLoS One. 2013;8(1):e50964. doi: 10.1371/journal.pone.0050964. Epub 2013 Jan 16.
9
Surface plasmon resonance spectroscopy study of interfacial binding of thrombin to antithrombin DNA aptamers.凝血酶与抗凝血酶DNA适配体界面结合的表面等离子体共振光谱研究。
J Colloid Interface Sci. 2007 Nov 1;315(1):99-106. doi: 10.1016/j.jcis.2007.06.040. Epub 2007 Aug 8.
10
Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method.使用蛋白质竞争者和适配体印迹法筛选针对VEGF165的DNA适配体。
Biotechnol Lett. 2008 May;30(5):829-34. doi: 10.1007/s10529-007-9629-6. Epub 2008 Jan 4.

引用本文的文献

1
Gold Nanoprism Enhanced SERS Aptasensor for Simultaneous Detection of Thrombin and VEGF.金纳米棱柱状增强表面增强拉曼散射适配体传感器用于同时检测凝血酶和血管内皮生长因子
Sens Actuators B Chem. 2025 Jan 15;423. doi: 10.1016/j.snb.2024.136811. Epub 2024 Oct 19.
2
Recent Advances in Aptamer-Based Biosensors for Bacterial Detection.基于适体的细菌检测生物传感器的最新进展。
Biosensors (Basel). 2024 Apr 23;14(5):210. doi: 10.3390/bios14050210.
3
Rational Approach to Optimizing Conformation-Switching Aptamers for Biosensing Applications.优化构象转换适体用于生物传感应用的合理方法。

本文引用的文献

1
Improvement of Aptamer Affinity by Dimerization.通过二聚化提高适体亲和力。
Sensors (Basel). 2008 Feb 19;8(2):1090-1098. doi: 10.3390/s8021090.
2
Aptamers as a model for functional evaluation of LNA and 2'-amino LNA.适体作为锁核酸(LNA)和2'-氨基锁核酸(2'-amino LNA)功能评估的模型。
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6585-7. doi: 10.1016/j.bmcl.2009.10.039. Epub 2009 Oct 13.
3
Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes.
ACS Sens. 2024 Feb 23;9(2):717-725. doi: 10.1021/acssensors.3c02004. Epub 2024 Jan 25.
4
VEGF Detection via Impedance Spectroscopy on Surface Functionalized Interdigitated Biosensor.通过表面功能化叉指式生物传感器上的阻抗谱检测血管内皮生长因子
J Funct Biomater. 2023 Jul 12;14(7):365. doi: 10.3390/jfb14070365.
5
bioTCIs: Middle-to-Macro Biomolecular Targeted Covalent Inhibitors Possessing Both Semi-Permanent Drug Action and Stringent Target Specificity as Potential Antibody Replacements.生物 TCIs:具有半永久药物作用和严格靶标特异性的中到大分子生物靶向共价抑制剂,可作为潜在的抗体替代品。
Int J Mol Sci. 2023 Feb 9;24(4):3525. doi: 10.3390/ijms24043525.
6
A comparative study of aptamer isolation by conventional and microfluidic strategies.常规与微流控策略分离适体的对比研究。
Analyst. 2023 Feb 13;148(4):787-798. doi: 10.1039/d2an01767a.
7
Targeting a conserved structural element from the SARS-CoV-2 genome using l-DNA aptamers.使用l-DNA适配体靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组中的一个保守结构元件。
RSC Chem Biol. 2021 Oct 20;3(1):79-84. doi: 10.1039/d1cb00172h. eCollection 2022 Jan 5.
8
Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer.用于卵巢癌的波形蛋白结合适体基序的选择和表征。
Molecules. 2021 Oct 28;26(21):6525. doi: 10.3390/molecules26216525.
9
Lipid-oligonucleotide conjugates for bioapplications.用于生物应用的脂质 - 寡核苷酸缀合物。
Natl Sci Rev. 2020 Jul 9;7(12):1933-1953. doi: 10.1093/nsr/nwaa161. eCollection 2020 Dec.
10
High-Throughput Selection and Characterisation of Aptamers on Optical Next-Generation Sequencers.高通量筛选和光学下一代测序仪上适配体的表征。
Int J Mol Sci. 2021 Aug 25;22(17):9202. doi: 10.3390/ijms22179202.
足细胞产生稳态趋化因子基质细胞衍生因子-1/CXCL12,它有助于 2 型糖尿病小鼠模型中的肾小球硬化、足细胞丢失和白蛋白尿。
Diabetologia. 2009 Nov;52(11):2445-54. doi: 10.1007/s00125-009-1493-6. Epub 2009 Aug 26.
4
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.富含鸟嘌呤的寡核苷酸AS1411作为癌症新疗法的发现与开发。
Exp Mol Pathol. 2009 Jun;86(3):151-64. doi: 10.1016/j.yexmp.2009.01.004. Epub 2009 Jan 20.
5
Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779.抗血管性血友病因子A1结构域适配体ARC1779对血管性血友病因子介导的血小板活化和血栓形成的抑制作用
J Thromb Haemost. 2009 Jul;7(7):1155-62. doi: 10.1111/j.1538-7836.2009.03459.x. Epub 2009 Apr 24.
6
Biophysical characterization of DNA aptamer interactions with vascular endothelial growth factor.DNA适配体与血管内皮生长因子相互作用的生物物理特性
Biopolymers. 2009 Feb;91(2):145-56. doi: 10.1002/bip.21097.
7
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.稳定性冠状动脉疾病患者中抗凝血剂控制因子IXa活性的1b期随机研究。
Circulation. 2008 Jun 3;117(22):2865-74. doi: 10.1161/CIRCULATIONAHA.107.745687. Epub 2008 May 27.
8
Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin.用于高效生成抗肉毒杆菌神经毒素单链DNA适配体的单微珠SELEX技术
Chem Commun (Camb). 2008 Apr 28(16):1883-5. doi: 10.1039/b717936g. Epub 2008 Mar 18.
9
Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.使用 Spiegelmer mNOX-E36-3'PEG 延迟阻断 Ccl2 可预防 db/db 小鼠的肾小球硬化并提高肾小球滤过率。
Am J Pathol. 2008 Mar;172(3):628-37. doi: 10.2353/ajpath.2008.070601. Epub 2008 Feb 7.
10
Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method.使用蛋白质竞争者和适配体印迹法筛选针对VEGF165的DNA适配体。
Biotechnol Lett. 2008 May;30(5):829-34. doi: 10.1007/s10529-007-9629-6. Epub 2008 Jan 4.